Statements (23)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:chemical_compound
|
| gptkbp:CASNumber |
6832-69-7
|
| gptkbp:chemicalFormula |
C22H25ClN4O
|
| gptkbp:drugClass |
inverse agonist at CB1 receptor
|
| gptkbp:effect |
modulates neurotransmitter release
affects memory and learning in animal models suppresses appetite in animal studies |
| gptkbp:heldBy |
cannabinoid receptor antagonist
|
| https://www.w3.org/2000/01/rdf-schema#label |
AM251
|
| gptkbp:IUPACName |
1-(2,4-dichlorophenyl)-5-(4-iodophenyl)-4-methyl-N-(piperidin-1-yl)-1H-pyrazole-3-carboxamide
|
| gptkbp:legalStatus |
not approved for medical use
|
| gptkbp:molecularWeight |
380.91 g/mol
|
| gptkbp:PubChem_CID |
CHEMBL127
3083545 |
| gptkbp:relatedTo |
gptkb:SR141716A
gptkb:rimonabant |
| gptkbp:routeOfAdministration |
experimental
|
| gptkbp:studiedBy |
gptkb:pharmacy
neuroscience |
| gptkbp:target |
gptkb:CB1_receptor
|
| gptkbp:UNII |
6LR8C1B0AG
|
| gptkbp:bfsParent |
gptkb:CB1_receptor
|
| gptkbp:bfsLayer |
7
|